A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression

References

• Atale A, Bonneau-Amati P, Rotig A, Fischer A, Perez-Martin S, de Lonlay P, Niaudet P, et al. (2009). Tubulopathy and pancytopaenia with normal pancreatic function: A variant of Pearson syndrome. Eur J Med Genet 52:23–6
   PubMed Web of Science ®Google Scholar
• Ayed IB, Chamkha I, Mkaouar-Rebai E, Kammoun T, Mezghani N, Chabchoub I, Aloulou H, et al. (2011). A Tunisian patient with Pearson syndrome harboring the 4.977kb common deletion associated to two novel large-scale mitochondrial deletions. Biochem Biophys Res Commun 411:381–6
   PubMed Web of Science ®Google Scholar
• Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, Polak MA, Koontz DA, Wallace DC. (1992). Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1:11–15
   PubMed Web of Science ®Google Scholar
• Blackwood JK, Whittaker RG, Blakely EL, Alston CL, Turnbull DM, Taylor RW. (2010). The investigation and diagnosis of pathogenic mitochondrial DNA mutations in human urothelial cells. Biochem Biophys Res Commun 393:740–5
   PubMed Web of Science ®Google Scholar
• Gibson KM, Bennett MJ, Mize CE, Jakobs C, Rotig A, Munnich A, Lichter-Konecki U, et al. (1992). 3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects. J Pediatr 121:940–2
   PubMed Web of Science ®Google Scholar
• Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, Tassone F, et al. (2010). Mitochondrial dysfunction in autism. JAMA 304:2389–96
   PubMed Web of Science ®Google Scholar
• Grady JP, Campbell G, Ratnaike T, Blakely EL, Falkous G, Nesbitt V, Schaefer AM, et al. (2014). Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain 137:323–34
   PubMed Web of Science ®Google Scholar
• Katada S, Mito T, Ogasawara E, Hayashi J, Nakada K. (2013). Mitochondrial DNA with a large-scale deletion causes two distinct mitochondrial disease phenotypes in mice. G3 (Bethesda, Md) 3:1545–52
   PubMed Web of Science ®Google Scholar
• Lee HF, Lee HJ, Chi CS, Tsai CR, Chang TK, Wang CJ. (2007). The neurological evolution of Pearson syndrome: Case report and literature review. Eur J Paediatr Neurol 11:208–14
   PubMed Web of Science ®Google Scholar
• Li CH, Lam CW, Lee CW, Kwong NS, Szeto SC. (2003). Pearson’s syndrome: A rare cause of non-immune hydrops fetalis. Chin Med J 116:1952–4
   PubMed Web of Science ®Google Scholar
• Malik AN, Czajka A. (2013). Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion 13:481–92
   PubMed Web of Science ®Google Scholar
• Manea EM, Leverger G, Bellmann F, Stanescu PA, Mircea A, Lèbre AS, Rötig A, et al. (2009). Pearson syndrome in the neonatal period: Two case reports and review of the literature. J Pediatr Hematol/Oncol 31:947–51
   PubMed Web of Science ®Google Scholar
• McShane MA, Hammans SR, Sweeney M, Holt IJ, Beattie TJ, Brett EM, Harding AE. (1991). Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 48:39–42
   PubMed Web of Science ®Google Scholar
• Morris AA, Lamont PJ, Clayton PT. (1997). Pearson’s syndrome without marrow involvement. Arch Dis Child 77:56–7
   PubMed Web of Science ®Google Scholar
• Muraki K, Nishimura S, Goto Y, Nonaka I, Sakura N, Ueda K. (1997). The association between haematological manifestation and mtDNA deletions in Pearson syndrome. J Inherit Metab Dis 20:697–703
   PubMed Web of Science ®Google Scholar
• Nicolino M, Ferlin T, Forest M, Godinot C, Carrier H, David M, Chatelain P, et al. (1997). Identification of a large-scale mitochondrial deoxyribonucleic acid deletion in endocrinopathies and deafness: Report of two unrelated cases with diabetes mellitus and adrenal insufficiency, respectively. J Clin Endocrin Metab 82:3063–7
   PubMed Web of Science ®Google Scholar
• Rieder MJ, Taylor SL, Tobe VO, Nickerson DA. (1998). Automating the identification of DNA variations using quality-based fluorescence re-sequencing: Analysis of the human mitochondrial genome. Nucleic Acids Res 26:967–73
   PubMed Web of Science ®Google Scholar
• Rotig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, Romero N, Schmitz J, et al. (1990). Pearson’s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 86:1601–8
   PubMed Web of Science ®Google Scholar
• Sadikovic B, Wang J, El-Hattab A, Landsverk M, Douglas G, Brundage EK, Craigen WJ, et al. (2010). Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes. PloS One 5:e15687
   PubMed Web of Science ®Google Scholar
• Schapira AH. (2012). Mitochondrial diseases. Lancet 379:1825–34
   PubMed Web of Science ®Google Scholar
• Williams TB, Daniels M, Puthenveetil G, Chang R, Wang RY, Abdenur JE. (2012). Pearson syndrome: Unique endocrine manifestations including neonatal diabetes and adrenal insufficiency. Mol Genet Metab 106:104–7
   PubMed Web of Science ®Google Scholar